1996
DOI: 10.1093/spp/23.2.117
|View full text |Cite
|
Sign up to set email alerts
|

Biotechnology in Europe: contentions in the risk-regulation debate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Australia lagged behind other countries, notably in Europe (Shohet 1996), in establishing a framework for biotechnology regulation, despite earlier calls for such a framework (House of Representatives SCIST 1992). Even after the eventual establishment of such a framework in the form of the Office of the Gene Technology Regulator, the authority of this federal regulation was undermined by state moratoria on GMOs in every state of Australia (Deakin 2008).…”
Section: Summary Of Analysismentioning
confidence: 99%
“…Australia lagged behind other countries, notably in Europe (Shohet 1996), in establishing a framework for biotechnology regulation, despite earlier calls for such a framework (House of Representatives SCIST 1992). Even after the eventual establishment of such a framework in the form of the Office of the Gene Technology Regulator, the authority of this federal regulation was undermined by state moratoria on GMOs in every state of Australia (Deakin 2008).…”
Section: Summary Of Analysismentioning
confidence: 99%
“…While different European nations have taken different approaches to GM regulation, the general tendency, established by two European Union Directives and their amendments, has been to single out GMOs as a distinct category of organisms on the basis of the novel character of the process whereby they have been created and to regulate them with dedicated legislation (Jasanoff, 1995;Levidow et al, 1996;Shohet, 1996).…”
Section: Europementioning
confidence: 99%